Are Investors Undervaluing Nature's Sunshine Products, Inc. (NASDAQ:NATR) By 38%?
Key Insights Nature's Sunshine Products' estimated fair value is US$24.58 based on 2 Stage Free Cash Flow to Equity...
| Ticker |
NATR
|
| CIK | 0000275053 |
| SIC | 2834 |
| Sector | Manufacturing |
| Industry Category | Pharmaceutical Products |
| Industry Group | Pharmaceutical Preparations |
| Address | 2901 WEST BLUEGRASS BLVD., SUITE 100, LEHI, UT, 84043 |
| Website | naturessunshine.com |
| Phone | (801) 341-7900 |
| CEO | Terrence O. Moorehead |
| Employees | 850 |
Our team will help you customize a package that meets the needs of your business.
Request a Consultation|
Standardized FinancialsdocsIntrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals. For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards. Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics: |
|||||||||||||||||||||
|
Income Statement
|
Balance Sheet
|
||||||||||||||||||||
|
Cash Flow Statement
|
Calculations
|
||||||||||||||||||||
|
Latest NewsdocsIntrinio provides up-to-date news articles on every US company from various sources. Here are several examples: |
Are Investors Undervaluing Nature's Sunshine Products, Inc. (NASDAQ:NATR) By 38%?Key Insights Nature's Sunshine Products' estimated fair value is US$24.58 based on 2 Stage Free Cash Flow to Equity... 5 Revealing Analyst Questions From Nature's Sunshine’s Q1 Earnings CallNature’s Sunshine’s first quarter was marked by strong international performance and effective risk management amid a complex trading environment. The company’s results exceeded Wall Street’s expectations, with CEO Terrence Moorehead attributing the outperformance to robust demand in Asia Pacific and Europe. Moorehead highlighted, “Our strategy to refocus the business on high-velocity products that offer an attractive repay purchase opportunity continued to drive strong order growth, while the e Why Nature's Sunshine (NATR) Shares Are Getting Obliterated TodayShares of wellness products company Nature’s Sunshine (NASDAQ:NATR) fell 8.5% in the afternoon session after the company announced the pricing of a secondary stock offering by a major shareholder. The offering involves major shareholder Fosun Pharma USA selling up to 2.85 million shares at a price of $12.00 per share. Traders Digest Economic Data as US Equity Futures Gain Pre-BellUS equity futures were up ahead of Thursday's opening bell amid a deluge of economic data, including Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Amid Chipmaker Optimism, Eyes Turn to Fed Leadership SpeculationThe broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.4% and the actively trad |